谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

First Clinical Results from A Phase 1 Trial of PRT3789, a First-in-Class Intravenous SMARCA2 Degrader, in Patients with Advanced Solid Tumors with a SMARCA4 Mutation

T. A. Yap,A. Dowlati, I. Dagogo-Jack,J. Vibert,A. I. Spira,V. Moreno Garcia, S. R. Punekar,E. Calvo,G. P. Sonpavde,M. Awad,J. W. Riess,T. Hernandez-Guerrero, B. Herzberg,A. Italiano,A. Swalduz,P. LoRusso, E. F. Smit,E. B. Garon,W. Novotny,R. Guo

EUROPEAN JOURNAL OF CANCER（2024）

引用 0|浏览1
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要